Literature DB >> 6752045

Antigens in an adult T-cell leukemia virus-producer cell line: reactivity with human serum antibodies.

N Yamamoto, Y Hinuma.   

Abstract

Sera from patients with adult T-cell leukemia (ATL) or other diseases and from healthy adults, whose titers of antibodies against ATL-associated antigens (ATLA) had been determined by indirect immunofluorescence, were analysed by a procedure of immunoprecipitation followed by SDS-polyacrylamide gel electrophoresis. For this an ATL virus (ATLV)-producer cell line, MT-2, was labelled with [35S]-methionine. All 12 anti-ATLA-positive sera but none of the eight anti-ATLA-negative sera tested reacted specifically with four polypeptides with molecular weights of 70,000, 53,000, 36,000 and 24,000 daltons. Furthermore, enrichment of three polypeptides with molecular weights of 76,000, 43,000 and 28,000 daltons was observed on reaction with anti-ATLA-positive sera. In control experiments using ATLA-negative T-cell lines, Molt-4 and HPB-ALL, none of these seven polypeptides were precipitated by reaction with anti-ATLA-positive sera. All six anti-ATLA-positive sera tested were shown to react with a polypeptide with a molecular weight of 24,000 of purified ATLV.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752045     DOI: 10.1002/ijc.2910300306

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus.

Authors:  H Tozawa; H Komatsu; K Ohkata; T Nakajima; M Watanabe; Y Tanaka; M Arifuku
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP.

Authors:  A Bazarbachi; K Cwynarski; A Boumendil; H Finel; P Fields; K Raj; A Nagler; M Mohty; A Sureda; P Dreger; O Hermine
Journal:  Bone Marrow Transplant       Date:  2014-07-14       Impact factor: 5.483

3.  Experimental infection of cynomolgus monkeys with a human retrovirus, adult T-cell leukemia virus.

Authors:  N Yamamoto; M Hayami; A Komuro; J Schneider; G Hunsmann; M Okada; Y Hinuma
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

4.  Expression of HTLV-specific polypeptides in various human T-cell lines.

Authors:  Y Koyanagi; Y Hinuma; J Schneider; T Chosa; G Hunsmann; N Kobayashi; M Hatanaka; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

5.  Rat lymphoid cell lines with HTLV-I production. III. Transmission of HTLV-I into rats and analysis of cell surface antigens associated with HTLV-I.

Authors:  T Yoshiki; N Kondo; T Chubachi; M Tateno; T Togashi; T Itoh
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay.

Authors:  H Hoshino; M Shimoyama; M Miwa; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

7.  Detection of antibodies to adult T-cell leukemia (ATL)-associated virus in ATL patients' sera by immunoelectron microscopy.

Authors:  Y Ohtsuki; T Akagi; K Takahashi; I Miyoshi
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

8.  Genomic structure of HTLV (human T-cell leukemia virus): detection of defective genome and its amplification in MT-2 cells.

Authors:  N Kobayashi; H Konishi; H Sabe; K Shigesada; T Noma; T Honjo; M Hatanaka
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

9.  Translation of HTLV (human T-cell leukemia virus) RNA in a nuclease-treated rabbit reticulocyte system.

Authors:  N Kobayashi; N Yamamoto; Y Koyanagi; J Schneider; G Hunsmann; M Hatanaka
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

10.  Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization.

Authors:  M Tateno; N Kondo; T Itoh; T Chubachi; T Togashi; T Yoshiki
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.